Article Versions Notes

Hirayama Y, Daniels NF, Evans S, Clarke D, Purvis S, Oliver C, Woodmansey S, Staniforth J, Soilleux EJ. High Prevalence of Pre-Existing Liver Abnormalities Identified Via Autopsies in COVID-19: Identification of a New Silent Risk Factor? Diagnostics. 2021; 11(9):1703. https://doi.org/10.3390/diagnostics11091703

Hirayama, Yuri, Natasha Faye Daniels, Shelley Evans, David Clarke, Stephenie Purvis, Charlotte Oliver, Stephen Woodmansey, Joy Staniforth, and Elizabeth J. Soilleux. 2021. "High Prevalence of Pre-Existing Liver Abnormalities Identified Via Autopsies in COVID-19: Identification of a New Silent Risk Factor?" Diagnostics 11, no. 9: 1703. https://doi.org/10.3390/diagnostics11091703

Hirayama, Y., Daniels, N. F., Evans, S., Clarke, D., Purvis, S., Oliver, C., Woodmansey, S., Staniforth, J., & Soilleux, E. J. (2021). High Prevalence of Pre-Existing Liver Abnormalities Identified Via Autopsies in COVID-19: Identification of a New Silent Risk Factor? Diagnostics, 11(9), 1703. https://doi.org/10.3390/diagnostics11091703